Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: Population-based study

Journal of the Royal Society of Medicine

Volumn 106, Issue 6, 2013, Pages 234-242

  Mukhtar, Toqir K ^a   Yeates, David R G ^a   Goldacre, Michael J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CAUSE OF DEATH; DEATH CERTIFICATE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL SOCIETY; UNITED KINGDOM; BREAST TUMOR; EARLY DIAGNOSIS; EVALUATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; RADIOGRAPHY; STATISTICS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

MLCS; MLOWN;

EID: 84880100175     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/0141076813486779     Document Type: Article

References (27)

1. International Agency for Research on Cancer. Cancer Fact Sheet: Breast Cancer Incidence, Mortality and Prevalence Worldwide in 2008, Summary. See http://globocan.iarc.fr/ factsheets/cancers/breast.asp (last checked 12 April 2013)
2. Autier P, Boniol M, La Vecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620
3. Cancer Research UK. Cancer Stats Breast Cancer - UK. May2009. See http://publications.cancerresearchuk.org/downloads/ Product/CS_CS_BREAST.pdf (last checked 12 April 2013)
4. Bock K, Borisch B, Cawson J, et al. Effect of population-based screening on breast cancer mortality. Lancet 2011;378:1775-6
5. Jørgensen KJ, Keen JD, Gøtzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology 2011;260:621-7
6. The Independent UK Panel on Breast Cancer Screening. The Benefits and Harms of Breast Cancer Screening: An Independent Review. See http://www.cancerresearchuk.org/prod_ consump/groups/cr_common/@nre/@pol/documents/ generalcontent/breast-screening-report.pdf (last checked 12 April 2013)
7. Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ (Clin Res Ed) 2013;346:f385
8. Gotzsche PC. The Nordic Cochrane Centre's comments on "Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012 Oct 30." See http://www.cochrane.dk/ screening/comments-on-UK-panel.htm (last checked 12 April 2013)
9. Kirwan CC. Breast cancer screening: what does the future hold? BMJ (Clin Res Ed) 2013;346:f87
10. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Vol 1, 9th revision. Geneva: WHO, 1977
11. Office for National Statistics. Mortality Statistics. Cause 1993 (revised) and 1994. Series DH2 (21). London: Office for National Statistics, 1996
12. Office for National Statistics. Mortality Statistics. Cause 2001. Series DH2 (28). London: Office for National Statistics, 2002
13. National Cancer Institute. Joinpoint Regression Program, Version 3.5.2. October 2011. Statistical Methodology and Applications Branch and Data Modeling Branch, Surveillance Research Program. See https://surveillance. cancer.gov/joinpoint/download (last checked 12 April 2013)
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51
15. Kim HJ, Feuer EJ, Barret M, Yu B, Fay MP, Midthune D. Is the trend changing? Joinpoint regression analysis. 2009: Presentation obtained from the lead author on December 8, 2011
16. The NHS Information Centre, Workforce and Families. Breast Screening Programme, England, 2008-09. See http:// www.cancerscreening.nhs.uk/breastscreen/breast-statistics- bulletin-2008-09.pdf (last checked 12 April 2013)
17. McCowan C, Shearer J, Donnan PT, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 2008;99:1763-8
18. Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L. Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer 2000;89:293-9
19. Godlee F. Breast screening controversy continues. BMJ (Clin Res Ed) 2013;346:f477
20. Autier P, Koechlin A, Smans M, Vatten L, Boniol M. Mammography screening and breast cancer mortality in Sweden. J Natl Cancer Inst 2012;104:1080-93
21. Jorgensen KJ, Zahl PH, Gotzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ (Clin Res Ed) 2010;340:c1241
22. Jørgensen KJ, Gøtzsche PC. Who evaluates public health programmes? A review of the NHS Breast Screening Programme. JRSM 2010;103:14-20
23. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. New Engl J Med 2010;363:1203-10
24. Goldacre MJ, Duncan ME, Cook-Mozaffari P, Griffith M. Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979-1998. J Publ Health Med 2003;25:249-53
25. Duncan ME, Goldacre MJ. Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006. BJU Int 2011;107:40-5
26. Duncan ME, Goldacre MJ. Certification of deaths from diabetes mellitus and obesity in England: trends into the twenty-first century. J Publ Health (Oxford, England). Epub ahead of print 7 September 2012
27. Tabar L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260:658-63